- Home
- Seeking healthcare
- Overview of diseases
- Communicable diseases
- Nationally recommended vaccines
Nationally recommended vaccines
Find information on nationally recommended vaccinations for children and adults in Singapore.
Last updated 21 November 2024
On this page
National Childhood Immunisation Schedule
The National Childhood Immunisation Schedule (NCIS) comprises childhood vaccinations recommended as the standard of care for protection against vaccine preventable diseases that are of significant healthcare burden to Singapore or would be so without these vaccinations.
In consultation with the Expert Committee on Immunisation (ECI), MOH regularly reviews vaccination policies and inclusion of vaccines into the schedule, taking into consideration local disease burden, vaccine safety, efficacy and cost effectiveness of the vaccines. This ensures that the national recommendations for childhood vaccination are up to date.
The NCIS covers vaccinations against 14 diseases - tuberculosis, hepatitis B, diphtheria, tetanus, pertussis, poliovirus, Haemophilus influenzae type b, measles, mumps, rubella, varicella (chickenpox), pneumococcal disease, human papillomavirus and influenza.
Of these, vaccinations against measles and diphtheria are compulsory for children under the Infectious Diseases Act.
Table 1: National Childhood Immunisation Schedule
Vaccine | Birth | 2 months | 4 months | 6 months | 12 months | 15 months | 18 months | 2-4 years | 5-9 years | 10-11 years | 12-13 years | 13-14 years | 15-17 years |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bacillus Calmette-Guérin (BCG) | D1 | ||||||||||||
Hepatitis B (HepB) | D1 | D2 | D3 | ||||||||||
Diphtheria, tetanus and acellular pertussis (paediatric) (DTaP) | D1 | D2 | D3 | B1 | |||||||||
Tetanus, reduced diphtheria and acellular pertussis (Tdap) | B2 | ||||||||||||
Inactivated poliovirus (IPV) | D1 | D2 | D3 | B1 | B2 | ||||||||
Haemophilus influenzae type b (Hib) | D1 | D2 | D3 | B1 | |||||||||
Pneumococcal conjugate (PCV10 or PCV13) | D1 | D2 | B1 | ||||||||||
Pneumococcal polysaccharide (PPSV23) | One or two doses for children and adolescents age 2-17 years with specific medical condition or indication. | ||||||||||||
Measles, mumps and rubella (MMR) | D1 | D2 | |||||||||||
Varicella (VAR) | D1 | D2 | |||||||||||
Human papillomavirus (HPV2 or HPV4) | D1 (Females) | D2 (Females) | |||||||||||
Influenza (INF) | Annual vaccination or per season for all children 6 months to <5 years (6-59 months). | Annual vaccination or per season for children and adolescents age 5-17 years with specific medical condition or indication. | |||||||||||
1 D1, D2, D3: Dose 1, Dose 2, Dose 3 2 B1, B2: Booster 1, Booster 2 3 10-11, 12-13, 13-14 years: Primary 5, Secondary 1, Secondary 2 (Tdap, IPV, HPV (for females) and MMR (as catch-up) vaccines are provided as part of Health Promotion Board’s school-based vaccination programme) 4 MMR: Only the dose 2 is recommended to be given as part of the MMRV vaccine 5 Hep B: Doses 2 and 3 are recommended to be given as part of the 6-in-1 vaccine at 2 and 6 months, respectively | |||||||||||||
Download PDF version of the NCIS [PDF, 221 KB]
National Adult Immunisation Schedule
The National Adult Immunisation Schedule (NAIS) was established in November 2017 to provide guidance on vaccinations that persons age 18 years or older should adopt to protect themselves against vaccine-preventable diseases.
Certain adults are at increased risk of complications or susceptible to vaccine preventable diseases if they have not previously received the vaccination and are in contact with individuals who have the infection. Vaccinations recommended under the NAIS aim to prevent such infections among susceptible individuals and reduce complications, morbidity and mortality.
The NAIS was developed based on international best practice and the recommendations of the Expert Committee on Immunisation (ECI). Considerations include:
local disease burden;
age, occupation, pre-existing medical conditions, vaccination history;
vaccine safety, efficacy and cost effectiveness of the vaccines in preventing infections among susceptible individuals and reducing complications, morbidity and mortality.
The vaccines in the NAIS protect against the following 11 diseases – Influenza, pneumococcal disease, human papillomavirus, tetanus, diphtheria, pertussis, measles, mumps, hepatitis B, and varicella (chickenpox).
Table 2: National Adult Immunisation Schedule
Vaccine | 18-26 years | 27-64 years | ≥ 65 years |
|---|---|---|---|
Influenza (INF) | 1 dose annually or per season# | 1 dose annually or per season* | |
Pneumococcal conjugate (PCV13) | 1 dose#* | ||
Pneumococcal polysaccharide (PPSV23) | 1 or 2 doses (depending on indication)# | 1 dose* | |
Tetanus, reduced diphtheria and acellular pertussis (Tdap) | 1 dose during each pregnancy# | ||
Human papillomavirus (HPV2 or HPV4) | 3 doses^ (Females) | ||
Hepatitis B (HepB) | 3 doses^ | ||
Measles, mumps and rubella (MMR) | 2 doses^ | ||
Varicella (VAR) | 2 doses^ | ||
* Recommended for adults who meet age requirement # Recommended for adults with specific medical condition or indication ^ Recommended for adults who have not been previously vaccinated, or lack evidence of past infection or immunity | |||
Download PDF version of the NAIS [PDF, 135 KB]
Related content
More information
HPB Healthline: 1800-223-1313